Korean J Gastroenterol.
2000 Apr;35(4):475-483.
Apolipoprotein E Polymorphism and Cholesterol in Stones and Bile of Patients with Cholelithiasis
Abstract
- BACKGROUND/AIMS
Apolipoprotein E4 (apo E4) has been reported to be
a risk factor for cholesterol gallstone formation. As a cause of cholesterol
gallstone formation, increased hepatic uptake of cholesterol absorbed from
intestine and enhanced biliary cholesterol secretion in patients carrying apo
E4 genotype have been suggested, but there is little direct evidence supporting
cholesterol supersaturation in the bile. Furthermore, it is unclear whether apo
E polymorphism is associated with intrahepatic duct (IHD) stone formation.
We performed this study to elucidate the relationship between apo E genotypes
and the cholesterol content of bile and stones in patients with gallbladder (GB)
stones or IHD stones. METHODS:Fourty-seven patients with GB stones and 43 patients
with IHD stones were enrolled in this study. Apo E genotype, bile composition and
stone composition were analyzed. RESULTS: Apo E genotypes and cholesterol content
of stones were not significantly different between the patients with GB stone and
the patients with IHD stone. The bile composition and cholesterol content of gallstone
in the patients showed no significant difference according to apo E genotypes.
CONCLUSIONS
Apo E4 genotype is not associated with an enhanced biliary cholesterol
secretion and high cholesterol content in GB or IHD stones.